Trending News
News
News
JDRF and GNF Announce Innovative Diabetes Drug Discovery and Development Partnership
Program focuses on expanding pipeline of drugs for people with Type 1 Diabetes.
News
Lorus Therapeutics Announces Allowance of Patent for LOR-2040 in Japan
The Japanese patent protects LOR-2040 composition and its use in the treatment of cancer.
News
Novartis Begins Shipment of Fluvirin® Seasonal Influenza Vaccine for U.S. Market Ahead of Schedule
Company is providing 30 million doses of Fluvirin vaccine to support the annual seasonal influenza vaccination campaign.
News
Reprogramming Human Cells without Inserting Genes
Research Team at WPI and CellThera discovers a way to turn on stem cell genes in human skin cells without using viruses or inserting new genes.
News
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright
The collaboration is aimed to sequence genomic regions associated with psychiatric disease.
News
Boston University and Bruker Establish a Collaborative Effort in Glycomics and Advanced FTMS Applications
Collaboration focuses on the application of high performance ion trap mass spectrometry and FTMS to glycomics and proteomics applications.
News
Horizon Discovery Sign License Agreement with Ortho Biotech Oncology Research & Development
The agreement covers the licensing of certain X-MAN cell lines including major cancer causing genes and their matched normal genetic backgrounds.
News
Ligand and Organon Mutually Terminate Collaboration and License Agreement
Both the companies mutually terminate collaboration and license agreement, which Ligand assumed in connection with its acquisition of Pharmacopeia in December 2008.
News
Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration
The collaboration will create antibody based products targeted to complex cell surface receptors.
News
UF Scientists Program Blood Stem Cells to Become Vision Cells
Research suggests a potential treatment for one of the most common causes of vision loss in older people.
Advertisement